Michael C. James - Mar 18, 2025 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role: Director
Signature: /s/ Michael C. James
Stock symbol: GTHP
Transactions as of: Mar 18, 2025
Transactions value $: $41,295
Form type: 4
Date filed: 4/8/2025, 12:11 PM
Previous filing: Nov 22, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHP	Common Stock	Purchase	$15K	+150K	+133.01%	$0.10	263K	Mar 18, 2025	Direct	F1
transaction	GTHP	Common Stock	Purchase	$26.3K	+263K	+100.07%	$0.10	526K	Mar 18, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHP	Warrants	Purchase		+150K			150K	Mar 18, 2025	Common Stock	150K	$0.13	Direct	F1
transaction	GTHP	Warrants	Purchase		+263K	+175.3%		413K	Mar 18, 2025	Common Stock	263K	$0.13	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Mr. James, pursuant to which the Company agreed to sell, for a total price of $15,000, an aggregate of 150,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 150,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.
F2	In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Mr. James, whereby Mr. James agreed to exchange a $25,000 note payable and accrued interest of $1,295 for 262,945 units as described above.

Content

On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Mr. James, pursuant to which the Company agreed to sell, for a total price of $15,000, an aggregate of 150,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 150,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.

In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Mr. James, whereby Mr. James agreed to exchange a $25,000 note payable and accrued interest of $1,295 for 262,945 units as described above.